Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by Stockqueen77on Aug 11, 2021 4:13pm
264 Views
Post# 33686432

BULLSH!T

BULLSH!T
Emerald Health Therapeutics Comments on Board Resignation VANCOUVER, August 11, 2021 Further to its press release of August 6th, Emerald Health Therapeutics, Inc. (Emerald or the Company) (CSE: EMH; OTCQX: EMHTF) provides additional details regarding the resignation of Dr. Avtar Dhillon as director and executive chairman. On August 5th the Company became aware that Dr. Avtar Dhillon had been arrested in the United States and charged with violations of US federal securities laws with respect to trading in certain US companies unrelated to Emerald. On August 6th Dr. Dhillon resigned from all roles with the Company, as previously announced. On August 9th the Securities and Exchange Commission announced certain additional charges against Dr. Dhillon and certain other individuals not related to Emerald. None of the allegations in the charges against Dr. Dhillon or any of the other individuals charged mention any improper trading of Emerald securities and the Company is not able to comment on the veracity of any of the allegations made against Dr. Dhillon or any of the other individuals charged. The Company is not aware of any improper trading in Emerald securities and no allegations have been made against any other person associated with Emerald, including any of its officers or other directors. The Company and its legal counsel are currently considering whether there are any additional steps they can take in the best interests of the Company and its shareholders.
<< Previous
Bullboard Posts
Next >>